Information on this page is intended for UK healthcare professionals only and may contain promotional material
Optimising the use of steroids for IBD
PU-00831 April 2022
Information on this page is intended for UK healthcare professionals only and may contain promotional material
The information on the following pages is intended only for UK resident patients and have been prescribed Octasa, Entocort Enema or budesonide CR 3 mg Capsules
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to Tillotts Pharma UK Ltd on 01522813500 or uksafety@tillotts.com
You are about to leave tillotts.co.uk for an external website. Tillotts is not responsible for the content of other websites.